Interleukin-18 promoter polymorphisms and the disease progression of Hepatitis B virus-related liver disease

Translational Research

Volumn 153, Issue 2, 2009, Pages 91-96

  Migita, Kiyoshi ^a   Sawakami Kobayashi, Kazumi ^a   Maeda, Yumi ^a   Nakao, Kazuhiko ^a   Kondoh, Susumu ^a   Sugiura, Mika ^a   Kawasumi, Ryoko ^a   Segawa, Osamu ^a   Tajima, Hideji ^a   Machida, Masayuki ^a   Nakamura, Minoru ^a   Yano, Koji ^a   Abiru, Seigo ^a   Kawasaki, Eiji ^a   Yatsuhashi, Hiroshi ^a   Eguchi, Katsumi ^a   Ishibashi, Hiromi ^a  

^a NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIBODY; INTERLEUKIN 18;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLELE; ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE; GENOTYPE; HEPATITIS B; HUMAN; INTERLEUKIN 18 GENE; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 58149471090     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2008.11.008     Document Type: Article

References (25)

1. Lee W.M. Hepatitis B virus infection. N Engl J Med 337 (1997) 1733-1745
2. Tassopoulos N.C., Papaevangelou G.J., Sjogren M.H., Roumeliotou-Karayannis A., Gerin J.L., and Purcell R.H. Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults. Gastroenterology 92 (1987) 1844-1850
3. Thursz M.R. Host genetic factors influencing the outcome of hepatitis. J Viral Hepatitis 4 (1997) 215-220
4. Wang C., Tang J., Song W., Lobashevsky E., Wilson C.M., and Kaslow R.A. HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination. Hepatology 39 (2004) 978-988
5. Bataller R., North K.E., and Brenner D.A. Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal. Hepatology 37 (2003) 493-503
6. Rapicetta M., Ferrari C., and Levrero M. Viral determinants and host immune responses in the pathogenesis of HBV infection. J Med Virol 67 (2002) 454-457
7. Okamura H., Tsutsi H., Komatsu T., et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378 (1995) 88-91
8. McInnes I.B., Gracie J.A., Leung B.P., Wei X.Q., and Liew F.Y. Interleukin 18: a pleiotropic participant in chronic inflammation. Immunol Today 21 (2000) 312-315
9. Giedraitis V., He B., Huang W.X., and Hillert J. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol 112 (2001) 146-152
10. Kamisango K., Kamogawa C., Sumi M., et al. Quantitative detection of hepatitis B virus by transcription-mediated amplification and hybridization protection assay. J Clin Microbiol 37 (1999) 310-314
11. McMahon B.J. Epidemiology and natural history of hepatitis B. Semin Liver Dis 25 (2005) 3-8
12. Bedossa P., and Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24 (1996) 289-293
13. Hagiwara H., Sawakami-Kobayashi K., Yamamoto M., et al. Development of an automated SNP analysis method using a paramagnetic beads handling robot. Biotechnol Bioeng 98 (2007) 420-428
14. Obata K., Segawa O., Yakabe M., et al. Development of a novel method for operating magnetic particles. Magtration Technology, and its use for automating nucleic acid purification. J Biosci Bioeng 91 (2001) 500-503
15. Sawakami-Kobayashi K., Segawa O., Obata K., et al. Multipurpose robot for automated cycle sequencing. Biotechniques 34 (2003) 634-637
16. Broderick A.L., and Jonas M.M. Hepatitis B in children. Semin Liver Dis 23 (2003) 59-68
17. Guidotti L.G., and Chisari F.V. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 19 (2001) 65-91
18. Osaki T., Peron J.M., Cai Q., et al. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects. J Immunol 160 (1998) 1742-1749
19. Pien G.C., Satoskar A.R., Takeda K., Akira S., and Biron C.A. Selective IL-18 requirements for induction of compartmental IFN-gamma responses during viral infection. J Immunol 165 (2000) 4787-4791
20. Kimura K., Kakimi K., Wieland S., Guidotti L.G., and Chisari F.V. Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice. J Virol 76 (2002) 10702-10707
21. Nakanishi K., Yoshimoto T., Tsutsui H., and Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 19 (2001) 423-474
22. Wei Y.S., Lan Y., Liu Y.G., Tang H., Tang R.G., and Wang J.C. Interleukin-18 gene promoter polymorphisms and the risk of esophageal squamous cell carcinoma. Acta Oncol 46 (2007) 1090-1096
23. Bouzgarrou N., Hassen E., Schvoerer E., et al. Association of interleukin-18 polymorphisms and plasma level with the outcome of chronic HCV infection. J Med Virol 80 (2008) 607-614
24. Zhang P.A., Wu J.M., Li Y., and Yang X.S. Association of polymorphisms of interleukin-18 gene promoter region with chronic hepatitis B in Chinese Han population. World J Gastroenterol 21 (2005) 1594-1598
25. Hirankarn N., Manonom C., Tangkijvanich P., and Poovorawan Y. Association of interleukin-18 gene polymorphism (-607A/A genotype) with susceptibility to chronic hepatitis B virus infection. Tissue Antigens 70 (2007) 160-163